Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
A
ACHILLES TENDINOSIS (1)
ACNE (6)
-
Endocannabinoid signaling and epidermal differentiation
-
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
-
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content
-
Dermatological Aspects of Synthetic Cannabinoid Addiction
-
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment
-
Targeting Cutaneous Cannabinoid Signaling in Inflammation â A âHighâ-way to Heal?
ACUPUNCTURE/ELECTROACUPUNCTURE (30)
-
Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats
-
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats
-
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
-
Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1
-
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors
-
Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats
-
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice
-
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain
-
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors
-
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum
-
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation
-
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint
-
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats
-
Acupuncture therapy for stroke patients
-
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke
-
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice
-
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension?
-
Cannabis-therapy for the future?
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke.
-
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice.
-
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension?
-
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions
-
Cannabis â therapy for the future?
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention
-
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats
-
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
ADD/ADHD (23)
-
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report
-
Panic Attack after Spice Abuse in a Patient with ADHD
-
Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter
-
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
-
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats
-
Impact of ADHD and cannabis use on executive functioning in young adults
-
Subtypes of Attention Deficit-Hyperactivity Disorder (ADHD) and Cannabis Use
-
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults
-
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
-
Use of paracetamol during pregnancy and child neurological development
-
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men
-
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder
-
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task
-
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey
-
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders
-
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients
-
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
-
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men
-
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats
-
Targeting the Endocannabinoid System in Psychiatric Illness
-
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults
ADDICTION/CRAVING/PROBLEMATIC USE (232)
-
Indian hemp and the dope fiends of Old England
-
Addictive Properties of Popular Drugs
-
Medical marijuana users in substance abuse treatment
-
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine
-
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults
-
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial
-
Characterizing smoking topography of cannabis in heavy users
-
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
-
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
-
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents
-
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use
-
Involvement of the endocannabinoid system in reward processing in the human brain
-
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence
-
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses
-
A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5
-
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
The genetic basis of the endocannabinoid system and drug addiction in humans
-
Reduction of dependence to cannabinoids by GLT-1 activating property of the betalactam antibiotic
-
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users
-
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
-
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis Users and Controls
-
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study
-
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction
-
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis
-
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
-
Probability and predictors of transition from abuse to dependence on alcohol, cannabis and cocaine: results from the national epidemiologic survey on alcohol and related conditions
-
Therapeutic potential of cannabinoid medicines
-
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
-
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems
-
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users
-
Low frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid
-
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
-
Role of CB2 Cannabinoid Receptor in the Rewarding, Reinforcing and Physical Effects of Nicotine
-
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
-
Biphasic effects of Î9-tetrahydrocannabinol on brain stimulation reward and motor activity
-
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence
-
Legalization of marijuana: unraveling quandaries for the addiction professional
-
Cannabis and Cigarettes
-
Endocannabinoid system and drug addiction: new insights from mutant mice approaches
-
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse
-
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference
-
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents
-
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones
-
Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence
-
Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals
-
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
-
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating
-
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls
-
The effects of cannabis use expectancies on self-initiated cannabis cessation
-
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice
-
Pregnenolone can protect the brain from cannabis intoxication
-
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
-
Systematic review of N-acetylcysteine in the treatment of addictions
-
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues
-
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches
-
Delta-9 tetrahydrocannabinol (THC) and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation (ICSS) in mice
-
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model
-
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health
-
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial
-
Evaluation of sex differences in cannabinoid dependence
-
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice
-
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats
-
Chronic stimulation of the tone of endogenous anandamide reduces cue â and stress induced relapse in rats
-
Cannabis Withdrawal in Patients With and Without Opioid Dependence
-
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing
-
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat
-
Investigation of sex-dependent effects of cannabis in daily cannabis smokers
-
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers
-
Expression and localization of cannabinoid receptor 1 in ratsâ brain treated with acute and repeated morphine
-
Imaging dopamine transmission parameters in cannabis dependence
-
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats
-
Changes in cigarette and alcohol use during cannabis abstinence
-
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats
-
Endocannabinoid signaling and food addiction
-
Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan
-
Cannabinoid modulation of drug reward and the implications of marijuana legalization
-
Neuroinflammation as a possible link between cannabinoids and addiction
-
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
-
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence
-
The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal
-
Etno-territorial prevalence of hashishism in some Siberian areas
-
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice
-
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.
-
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
-
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset
-
Role of the endogenous cannabinoid system in nicotine addiction: novel insights
-
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward
-
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements
-
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
-
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence
-
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area
-
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
Marijuana, Reconsidered: Dr Lester Grinspoon On 45 Years Of Cannabis Science
-
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts
-
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers
-
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use
-
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system
-
Further human evidence for striatal dopamine release induced by administration of â9-tetrahydrocannabinol (THC): selectivity to limbic striatum
-
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption
-
The hippocampal NMDA receptors may be involved in acquisition, but not expression of ACPA-induced place preference
-
The influence of cannabinoids on learning and memory processes of the dorsal striatum
-
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?
-
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity
-
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys
-
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment
-
Separate and combined effects of gabapentin and [delta]9-tetrahydrocananbinol in humans discriminating [delta]9-tetrahydrocananbinol
-
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
-
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial
-
Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys
-
Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist
-
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
-
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
-
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use
-
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens
-
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis
-
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies
-
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience
-
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function
-
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala
-
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
-
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex
-
Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population
-
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up
-
Mediating processes between stress and problematic marijuana use
-
Combined Treatment with Morphine and Î9-Tetrahydrocannibinol (THC) in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal
-
Are genetic variants for tobacco smoking associated with cannabis involvement?
-
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
-
Interactions between the endocannabinoid and nicotinic cholinergic s ystems: preclinical evidence and therapeutic perspectives
-
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use
-
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families
-
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors
-
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication
-
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
-
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence
-
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis
-
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys
-
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence
-
Attempts to Stop or Reduce Daily Cannabis Use: An Intensive Natural History Study
-
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice
-
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
-
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and structural responses to cocaine
-
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497
-
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial
-
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons
-
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol
-
BlackâWhite Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net?
-
Involvement of Endocannabinoids in Alcohol âBingeâ Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists
-
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males
-
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
-
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol SelfAdministration by Wistar Rats
-
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats
-
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders
-
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder
-
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users.
-
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats
-
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients
-
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1 receptors
-
Opioids Out, Cannabis In
-
Lipids in psychiatric disorders and preventive medicine
-
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
-
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use
-
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families
-
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication
-
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys
-
The Changing Drug Culture: Medical and Recreational Marijuana
-
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
-
Combined treatment with morphine and Î9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal
-
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
-
Alcohol and cannabis use among college students: Substitutes or complements?
-
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder
-
Cannabis policy and the uptake of treatment for cannabis-related problems.
-
Dermatological Aspects of Synthetic Cannabinoid Addiction
-
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.
-
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
-
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells
-
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women
-
Keep off the grass? Cannabis, cognition and addiction
-
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions
-
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women
-
Comorbid Cannabis and Tobacco Use in Adolescents and Adults
-
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions
-
A Functional 3âUTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits.
-
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified.
-
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men
-
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013
-
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series
-
Craving Cannabis: A Meta-analysis of Self-Report and Psychophysiological CueReactivity Studies
-
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects
-
Exercise as an adjunctive treatment for cannabis use disorder
-
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana
-
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats
-
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain
-
Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders
-
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
-
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus
-
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes
-
Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans
-
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC
-
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder
-
Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence
-
Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias
-
Contribution of health motive to cannabis use among high-school students
-
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.
-
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats
-
Does marijuana âbluntâ smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking
-
Genetic and Environmental Factors Associated with Cannabis Involvement
-
Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review
-
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
-
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
-
Child maltreatment and cannabis use in young adulthood: A birth cohort study
-
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives
-
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
-
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence
-
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function
-
Behavioral Determinants of Cannabinoid Self-Administration in Old-World Monkeys.
-
Synthetic cannabinoids: A new addiction matrix
-
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls.
-
Identifying HIV care enrollees at-risk for cannabis use disorder.
-
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study.
-
Marijuana Could Help Treat Drug Addiction and Mental Health Problems
-
Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder
-
Brain cannabinoid receptor 2: expression, function and modulation
-
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?
-
Whole genome sequence study of cannabis dependence in two independent cohorts
-
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians
ADOLESCENTS/YOUNG ADULTS (303)
-
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States
-
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects
-
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France
-
PTSD contributes to teen and young adult cannabis use disorders
-
Adolescent cannabis use increases risk for cocaine-induced paranoia
-
Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients
-
Cannabis Use and Obesity and Young Adults
-
A Life-course Perspective on the âGateway Hypothesisâ
-
The Effects of Cannabis on Heart Rate Variability and Well-Being in Young Men
-
Patterns of Youth Participation in Cannabis Cultivation
-
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
-
The social contagion effect of marijuana use among adolescents
-
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study
-
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States
-
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
-
The association between early conduct problems and early marijuana use in college students
-
Gender differences in adolescent marijuana use and associated psychosocial characteristics
-
Synthetic cannabinoid use: a case series of adolescents
-
Some features of teenage beer alcoholism combined with hashish addiction
-
Pediatric cannabinoid hyperemesis: two cases
-
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome
-
Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents
-
Does the âgatewayâ sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy
-
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey
-
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease
-
Adolescent Exposure of JWH-018 âSpiceâ Produces Subtle Effects on Learning and Memory Performance in Adulthood
-
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey
-
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use
-
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents
-
Medical Marijuana Laws and Teen Marijuana Use
-
Acute intoxication caused by a synthetic cannabinoid in two adolescents
-
Sensation-seeking genes and physical activity in youth
-
Do medical marijuana laws increase marijuana use? Replication study and extension
-
Alcohol as a Gateway Drug: A Study of US 12th Graders
-
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France
-
Adolescent Synthetic Cannabinoid Exposures Reported to Texas Poison Centers
-
âItâs just a social thingâ: Drug use, friendship and borderwork among marginalized young people
-
The changing demographic of blunt smokers across birth cohorts
-
Sex and grade level differences in marijuana use among youth
-
Water pipe smoking and psychoactive substances
-
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation
-
Identity Formation, Marijuana and âThe Selfâ: A Study of Cannabis Normalization among University Students
-
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status
-
Effects of State Medical Marijuana Laws on Adolescent Marijuana Use
-
Legalization of medical marijuana and marijuana use among youths
-
Weeding out the information: an ethnographic approach to exploring how young people sense of the evidence on cannabis
-
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum
-
Impact of ADHD and cannabis use on executive functioning in young adults
-
Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes
-
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study
-
Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse?
-
From âSocial Supplyâ to âReal Dealingâ: Drift, Friendship, and Trust in Drug-Dealing Careers
-
THE IMPORTANCE OF FAMILY RELATIONS FOR CANNABIS USERS: THE CASE OF SERBIAN ADOLESCENTS
-
Statistics on cannabis users skew perceptions of cannabis use
-
Higher rates of adolescent substance use in child welfare versus community populations in the United States
-
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence
-
Identity formation, marijuana and âthe selfâ: a study of cannabis normalization among university students
-
National-level drug policy and young peopleâs illicit drug use: A multilevel analysis of the European Union
-
To What Extent Does Adding Tobacco to Cannabis Expose Young Users to Nicotine?
-
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating
-
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene
-
Cannabis use among a sample of 16 to 18 year-old students in Switzerland
-
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents
-
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain
-
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States
-
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use
-
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults
-
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students
-
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health
-
Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization
-
Neurocognition in college-aged daily marijuana users
-
Cannabinoid findings in children hair â what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Î9-tetrahydrocannabinolic acid A concentrations
-
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana
-
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement?
-
What are young adults smoking in their hookahs? A latent class analysis of substances smoked
-
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers
-
Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates
-
The Impact of a Motivational Statement and Age of Cannabis Use Onset on Neuro-psychological Test Performance
-
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM
-
The co-use of tobacco and cannabis among adolescents over a 30-year period
-
Interpersonal Guilt and Substance Use in College Students
-
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents
-
Prevalence of Cannabis Lifetime Use in Iranian High School and College Students: A Systematic Review, Meta-Analyses, and Meta-Regression
-
Synthetic Cannabinoids: Use and predictors in a Community Sample of Young Adults
-
Cannabis use and suicidal ideations in high-school students
-
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers
-
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
-
Frequent electronic media communication with friends is associated with higher adolescent substance use
-
Medical marijuana and children
-
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM
-
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and Two Years of Decriminalization
-
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update
-
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America
-
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 Lâaquila Earthquake
-
Sex-dependent vulnerability to Cannabis abuse in adolescence
-
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit
-
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset
-
Impact of Cannabis Use on the Development of Psychotic Disorders
-
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race
-
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche
-
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
-
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014
-
High School Studentsâ Use of Electronic Cigarettes to Vaporize Cannabis
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States
-
Medical marijuanaâs public health lessons-implications for retail marijuana in Colorado
-
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence
-
E-Cigarettes: A Review of New Trends in Cannabis Use
-
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
-
The role of the Cannabinoid Receptor 1 in adolescentsâ processing of facial expressions
-
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom
-
Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
More people think cannabis should be legal than tobacco
-
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
-
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
-
Young adult cannabis users report greater propensity for risk-taking only in nonmonetary domains
-
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
-
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire
-
Synthetic cannabinoid use in a nationally representative sample of US high school seniors
-
Urinary early kidney injury molecules in children with beta-thalassemia major
-
Synthetic cannabinoid use in a nationally representative sample of US high school seniors
-
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington State and Victoria, Australia
-
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity
-
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence
-
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
-
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
-
Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men
-
K2 and Spice use among a cohort of college students in southeast region of the USA
-
Cigarette smoking may modify the association between cannabis use and adiposity in males
-
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients
-
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age
-
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
K2 and Spice use among a cohort of college students in southeast region of the USA
-
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis
-
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder
-
Teenage Cardiac Arrest Following Abuse of Synthetic Cannabis
-
Synthetic Cannabinoid Abuse in Adolescents: A Case Series
-
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task
-
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting
-
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies
-
Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones
-
CANNABIS: ALTERNATIVE REALITIES (CRA)
-
The Association of Low Parental Monitoring With Early Substance Use in European American and African American Adolescent Girls
-
Prevalence of Marijuana and Other Substance Use Before and After Washington Stateâs Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents
-
Who receives cannabis use offers: A general population study of adolescents
-
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
-
The Effect of Medical Marijuana Laws on Body Weight
-
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption
-
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex
-
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis
-
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries
-
IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
-
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use
-
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation
-
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience
-
Cannabis and Psychosis: a Critical Overview of the Relationship
-
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence
-
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice
-
Medicinal Use of Marijuana: What School Nurses Need to Know.
-
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats
-
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats
-
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center
-
Associations Between Cannabis Use and Physical Health Problems in Early Midlife
-
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011
-
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
-
National Estimates of Marijuana Use and Related Indicators â National Survey on Drug Use and Health, United States, 2002â2014
-
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
-
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol
-
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature
-
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling
-
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males
-
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation
-
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
-
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood
-
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
-
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
-
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
-
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
-
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats.
-
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people
-
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study.
-
The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado.
-
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients
-
Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study. (click ELSEVIER for link to
-
Use of marijuana for medical purposes. (click âfull Text Linksâ for
-
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation.
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation (click âMolecular Medicineâ for
-
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse â the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent â case report (link to
-
Dose of Reality: The Effect of State Marijuana Legalizations
-
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus
-
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families
-
Cannabis and Psychosis: a Critical Overview of the Relationship
-
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal
-
Experience with Gambling in Late Childhood and Early Adolescence: Implications for Substance Experimentation Behavior
-
Cannabis â Position Paper of the German Respiratory Society (DGP)
-
Lack of hippocampal CB1 receptor desensitization by Î9-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
-
Weeding Out the Truth: Adolescents and Cannabis
-
Alcohol and cannabis use among college students: Substitutes or complements?
-
Mitigation of Marijuana-Related Legal Harms to Youth in California
-
Age of Sexual Debut and Cannabis Use in the United States
-
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene
-
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder
-
Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men
-
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
-
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women
-
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults
-
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner.
-
Comorbid Cannabis and Tobacco Use in Adolescents and Adults.
-
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students.
-
Childhood Maltreatment in the Migraine Patient.
-
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation
-
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults.
-
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions
-
Influence of legal status on the uptake of cannabis in young people.
-
Racial Differences and the Role of Neighborhood in the Sequencing of Marijuana and Tobacco Initiation Among Urban Youth.
-
Decision-Making Does not Moderate the Association between Cannabis Use and Body Mass Index among Adolescent Cannabis Users.
-
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified.
-
Neural mechanisms of sensitivity to peer information in young adult cannabis users.
-
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men
-
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013
-
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes.
-
Marijuana-Related Posts on Instagram
-
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study
-
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature.
-
Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
-
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents
-
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana
-
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes.
-
Pediatric oncology providers and use of medical marijuana in children with cancer
-
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
-
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users
-
Childhood weight status and timing of first substance use in an ethnically diverse sample
-
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
-
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States
-
Cross-section and panel estimates of peer effects in early adolescent cannabis use: With a little help from my âfriends once removedâ
-
Alveolar haemorrhage following a cannabis water pipe
-
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents
-
Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans
-
Understanding resilience: New approaches for preventing and treating PTSD
-
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015
-
Adolescent cannabis use: What is the evidence for functional brain alteration?
-
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation
-
Consuming energy drinks at the age of 14 predicted legal and illegal substance use at 16
-
Cannabinoids and Psychosis (3)
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High.
-
Contribution of health motive to cannabis use among high-school students.
-
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.
-
Disturbances of sleep and circadian rhythms: novel risk factors for obesity.
-
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany.
-
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data.
-
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
Abnormal white matter integrity in synthetic cannabinoid users
-
Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults
-
Risky substance use and peer pressure in Swiss young men: Test of moderation effects.
-
The Synthetic Cannabinoids Phenomenon.
-
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use.
-
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis
-
Child maltreatment and cannabis use in young adulthood: A birth cohort study
-
âJust one bad high:â considering synthetic cannabinoid outcome expectancies in adolescents.
-
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys.
-
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy.
-
The neurobiology of social play and its rewarding value in rats
-
Prevalence and correlates of âVapingâ as a route of cannabis administration in medical cannabis patients
-
A social network analysis of substance use among immigrant adolescents in six European cities
-
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado
-
The Normalization of Cannabis Use Among Bangladeshi and Pakistani Youth: A New Frontier for the Normalization Thesis?
-
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population?
-
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease
-
From niche to stigma-Headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults
-
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors
-
The consequences of chronic cannabis smoking in vulnerable adolescents
-
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma
-
Is the Legalization of Marijuana Associated With Its Use by Adolescents?
-
Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults
-
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults
-
Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder.
-
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to
-
Rocky Mountain High: Preventing Cannabis-Related Injuries
-
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users.
-
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults
-
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood
-
Self-reported Driving Under the Influence of Alcohol and Cannabis Among Ontario Students: Associations with Graduated Licensing, Risk Taking and Substance Abuse
-
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians
-
Cannabis use, COMT, BDNF and age at first-episode psychosis
ADRENOLEUKODYSTROPHY (1)
AGING (46)
-
The Management of Chronic Pruritus in the Elderly
-
N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans
-
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
-
The effects of Cannabis sativa L. seed (hempseed) in the ovariectomized rat model of menopause
-
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation
-
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
-
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470
-
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice
-
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET
-
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women
-
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?
-
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory
-
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
-
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
-
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats
-
Review article: The endocannabinoid system in normal and pathological brain ageing
-
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake
-
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour
-
Combined deficiency of the CB1 and CB2 receptors enhances peak bone mass by inhibiting osteoclast differentiation but increases age-related bone loss by promoting adipocyte differentiation and reducing osteoblast differentiation
-
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health
-
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism
-
Anandamide deficiency and heightened neuropathic pain in aged mice
-
Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus
-
GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses
-
Differential effects of delayed aging on phenotype and striatal pathology in a murine model of huntington disease
-
Endocannabinoid signalling and the deteriorating brain
-
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans
-
Plasma-Free Fatty Acids, Fatty Acid-Binding Protein 4 and Mortality in Older Adults (from the Cardiovascular Health Study)
-
The endocannabinoid system and appetite: relevance for food reward
-
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists
-
Enhanced microglial activity in FAAH-/- animals
-
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging
-
Endocannabinoid signalling and the deteriorating brain
-
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimerâs Disease
-
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction
-
Age-related changes in the endocannabinoid system in the mouse hippocampus
-
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice
-
The Effect of Medical Marijuana Laws on Body Weight
-
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats
-
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimerâs Disease and Mild Cognitive Impairment
-
Lack of hippocampal CB1 receptor desensitization by Î9-tetrahydrocannabinol in aged mice and by low doses of JZL 184
-
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets
-
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
-
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia
-
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia
-
β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro.
ALCOHOLISM/ALCOHOL (192)
-
The use of Cannnabidiol (CBD) to Reduce Insomnia and the Urge To Use Alcohol in a Geriatric person in on going Behavior Therapy.
-
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy
-
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy.
-
Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women
-
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis
-
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects
-
The Endocannabinoid System Tonically Regulates Inhibitory Transmission and Depresses the Effect of Ethanol in Central Amygdala
-
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides
-
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users
-
11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption
-
Role of the endocannabinoid system in alcoholic liver disease
-
The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand
-
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde
-
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
-
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults
-
Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans
-
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions
-
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers
-
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice
-
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males
-
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States
-
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?
-
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET
-
The role of the cannabinoid system in the pathogenesis and treatment of alcohol dependence
-
Some features of teenage beer alcoholism combined with hashish addiction
-
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption
-
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses
-
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders
-
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST
-
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol
-
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption
-
Involvement of the Endocannabinoid System in Ethanol-Induced Corticostriatal Synaptic Depression
-
Effects of ethanol, Î(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats
-
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence
-
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients
-
Alcohol as a Gateway Drug: A Study of US 12th Graders
-
Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests
-
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice
-
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats
-
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders
-
Perception of tobacco, cannabis, and alcohol use of others is associated with oneâs own use
-
Influence of Ethanol on the Pharmacokinetic Properties of Î9-Tetrahydrocannabinol in Oral Fluid
-
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH
-
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance
-
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption
-
Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the national epidemiologic survey on alcohol and related conditions
-
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
-
Differential expression and functional role of cannabinoid genes in alcohol users
-
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
-
Effect of Diet on Tissue Levels of Palmitoylethanolamide
-
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats
-
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse
-
Lifetime prevalence of alcohol and substance use in egypt: a community survey
-
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption
-
Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study
-
Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics
-
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid mediated gastroprotective effect in rats
-
Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden
-
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex
-
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis
-
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders
-
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats
-
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana
-
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A diary analysis
-
Can Cannabis be Considered a Substitute Medication for Alcohol?
-
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
-
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence
-
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health
-
Effects of Î9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism
-
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls
-
Changes in cigarette and alcohol use during cannabis abstinence
-
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use
-
Recreational drug use and binge drinking: Stimulant but not cannabis intoxication is associated with excessive alcohol consumption
-
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice
-
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects
-
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles
-
Gene-Specific Disruption of Endocannabinoid Receptor 1 (cnr1a) by Ethanol Probably Leads to the Development of Fetal Alcohol Spectrum Disorder (FASD) Phenotypes in Japanese Rice Fish (Oryzias latipes) Embryogenesis
-
Drug and Alcohol Crash Risk
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
-
Drugs of Abuse in HIV infection and neurotoxicity
-
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 Lâaquila Earthquake
-
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
-
Drug and Alcohol Crash Risk
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
-
Drugs of Abuse in HIV infection and neurotoxicity
-
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 Lâaquila Earthquake
-
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
-
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
-
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
Profiles of medicinal cannabis patients attending compassion centers in rhode island
-
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption
-
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neuro-degeneration in neonatal mice
-
European rating of drug harms
-
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala
-
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model
-
Roles for the endocannabinoid system in ethanol-motivated behavior
-
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age
-
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects
-
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships
-
Drug and Alcohol Crash Risk
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
-
Drugs of Abuse in HIV infection and neurotoxicity
-
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 Lâaquila Earthquake
-
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
-
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol
-
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults
-
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials
-
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain
-
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)
-
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons
-
Prenatal exposure to recreational drugs affects global motion perception in preschool children
-
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
-
Profiles of medicinal cannabis patients attending compassion centers in rhode island
-
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption
-
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice
-
European rating of drug harms
-
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala
-
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model
-
Roles for the endocannabinoid system in ethanol-motivated behavior
-
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age
-
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects
-
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships
-
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus
-
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression
-
Tetrahydrocannabinol pharmacokinetics â new synthetic cannabinoids â road safety and cannabis
-
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
-
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats
-
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats
-
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala
-
Prevalence of Marijuana and Other Substance Use Before and After Washington Stateâs Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents
-
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours
-
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism
-
The Effect of Medical Marijuana Laws on Body Weight
-
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
-
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption
-
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats
-
Behavioral, Metabolic and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model
-
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
-
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use
-
Impacts of Changing Marijuana Policies on Alcohol Use in the United States
-
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use
-
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families
-
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors
-
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking
-
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication
-
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala
-
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice
-
Effect of Blood Collection Time on Measured Î9-Tetrahydrocannabinol Concentrations:
-
Implications for Driving Interpretation and Drug Policy
-
Alcohol and cannabis use among college students: Substitutes or complements?
-
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
-
Cannabis effects on driving longitudinal control with and without alcohol
-
ALCOHOL DEPENDENCEâNEUROBIOLOGY AND TREATMENT.
-
Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta.
-
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified
-
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men.
-
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms.
-
Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders.
-
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatientsâ Daily Lives.
-
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.
-
Traffic accidentability and risky driving behavior in young people in New Caledonia. of study
-
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature.
-
Drugs of abuse and alcohol consumption among different groups of population on the Greek Island of Lesvos through sewage-based epidemiology.
-
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents
-
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana.
-
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol.
-
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
-
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models
-
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes
-
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population
-
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
-
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats
-
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use
-
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
-
Child maltreatment and cannabis use in young adulthood: A birth cohort study
-
A social network analysis of substance use among immigrant adolescents in six European cities
-
Oxytocin for the treatment of drug and alcohol use disorders
-
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population?
-
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption. Study of neurobiological consequences.
-
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes.
-
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study.
-
Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults
-
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst â 2016
-
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife
-
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.
-
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood.
-
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD.
-
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse.
ALLERGIES AND CANNABIS (24)
-
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity
-
Protective role of palmitoylethanolamide in contact allergic dermatitis
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors
-
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways
-
Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs
-
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up regulation of Serum IgE Levels in Immunized Mice
-
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis
-
Endocannabinoids limit excessive mast cell maturation and activation in human skin
-
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
-
The cannabinoid receptor-2 is involved in allergic inflammation
-
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
-
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ
-
Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells
-
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation
-
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors
-
The expression of cannabinoid receptor 1 is significantly increased in atopic patients
-
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS
-
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
-
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergeninduced pulmonary inflammation in mice
-
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity
-
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
-
The Endocannabinoid System and Its Role in Eczematous Dermatoses
ALLERGIES TO CANNABIS (17)
-
Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users
-
IgE-Mediated Hypersensitivity Reactions to Cannabis in Laboratory Personnel
-
Molecular allergology in practice: an unusual case of LTP allergy
-
World Allergy Organization Study on Aerobiology for Creating First Pollen and Mold Calendar With Clinical Significance in Islamabad, Pakistan. A Project of World Allergy Organization and Pakistan Allergy, Asthma & Clinical Immunology Centre of Islamabad
-
Variations and origin of the atmospheric pollen of Cannabis detected in the province of Tetouan (NW Morocco): 2008-2010
-
Characterization of Cannabis sativa allergens
-
New Food Allergies in a European Non-Mediterranean Region: Is Cannabis sativa to Blame?
-
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma
-
Prevalence of Sensitization to Cannabis sativa. Lipid-Transfer and Thaumatin-Like Proteins Are Relevant Allergens
-
Contact urticaria to Cannabis sativa due to a lipid transfer protein (LTP)
-
Allergy to illicit drugs and narcotics
-
Cannabis Sativa: The Unconventional âWeedâ Allergen
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Marihuana allergy: beyond the joint
-
Cannabis Allergy: What do We Know Anno 2015
-
Marihuana allergy: beyond the joint.
-
Cannabis sativa allergy: looking through the fog
ALS/AMYOTROPHIC LATERAL SCLEROSIS (28)
-
Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
-
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis
-
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis
-
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia
-
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance
-
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
-
Medical Cannabis Helps ALS Patient Outlive her Own Doctors
-
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report
-
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress and cell death during remote neurodegeneration
-
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
-
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide
-
The endocannabinoid system: a putative role in neurodegenerative diseases
-
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
-
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
-
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
-
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.
-
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy
-
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
-
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis.
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Pain in amyotrophic lateral sclerosis.
-
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis
ALZHEIMERâS DISEASE/DEMENTIA (159)
-
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality
-
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons
-
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
-
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
-
The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies
-
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid
-
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia
-
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimersâ disease
-
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
-
Gadolinium-HU-308-incorporated micelles
-
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
An amyloid β(42)-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimerâs disease
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults
-
Molecular reorganization of endocannabinoid signalling in Alzheimerâs disease
-
Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide
-
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia
-
Patent WO 2010012506 A1 â CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA
-
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids?
-
JNK plays a key role in tau hyperphosphorylation in Alzheimerâs disease models
-
The role of phytochemicals in the treatment and prevention of dementia
-
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice
-
Intact cannabinoid CB1 receptors in the Alzheimerâs disease cortex
-
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway
-
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
-
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice
-
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimerâs disease
-
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimerâs Disease
-
βâAmyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors
-
Monoacylglycerol lipase is a new therapeutic target for Alzheimerâs disease
-
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
-
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
-
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
-
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
-
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
-
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats
-
Review article: The endocannabinoid system in normal and pathological brain ageing
-
[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimerâs disease
-
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones
-
Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity
-
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimerâs disease via regulation of β-secretase activity
-
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro
-
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
-
The therapeutic potential of the endocannabinoid system for Alzheimerâs disease
-
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
-
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimerâs disease patients
-
In vivo type 1 cannabinoid receptor availability in Alzheimerâs disease
-
Essential fatty acids and lipid mediators. Endocannabinoids
-
How Weed Can Protect Us From Cancer and Alzheimerâs
-
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
-
The Influence of Cannabinoids on Generic Traits of Neurodegeneration
-
R-flurbiprofen improves tau, but not AÃ pathology in a triple transgenic model of Alzheimerâs disease
-
Î9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling
-
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimerâs Disease
-
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice
-
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency
-
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimerâs disease patients
-
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
-
Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
-
Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model
-
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
-
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier
-
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimerâs disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
-
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
-
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
-
In vivo type 1 cannabinoid receptor availability in Alzheimerâs disease
-
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
-
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimerâs disease
-
Cannabinoids for treatment of Alzheimerâs disease: moving toward the clinic
-
The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimerâs Disease?
-
Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimerâs disorders using molecular docking and molecular dynamics simulation
-
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimerâs Disease
-
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
-
The endocannabinoid system: a putative role in neurodegenerative diseases
-
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimerâs Disease
-
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimerâs disease
-
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition
-
Endocannabinoid signalling and the deteriorating brain
-
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimerâs Disorders Using Molecular Docking and Molecular Dynamics Simulation
-
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
-
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice
-
Medical Cannabis Research, What the Science Says
-
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimerâs Disease
-
Endocannabinoid signaling in Alzheimerâs disease: current knowledge and future directions
-
Type-1 Cannabinoid Receptor Activity During Alzheimerâs Disease Progression
-
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor
-
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
-
The Potential Therapeutic Effects of THC on Alzheimerâs Disease
-
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimerâs Disease
-
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ÎE9 Mouse Model of Alzheimerâs Disease
-
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms
-
Type-1 Cannabinoid Receptor Activity During Alzheimerâs Disease Progression
-
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimerâs disease
-
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
-
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
-
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimerâs disease models: the control of neuroinflammation
-
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists
-
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1âE9 mice
-
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimerâs disease transgenic mice
-
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
-
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture
-
Cannabinoids in late-onset Alzheimerâs disease
-
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation
-
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection
-
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimerâs Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline
-
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling
-
The role of cannabinoids and leptin in neurological diseases
-
Advancements in the treatment of agitation in Alzheimerâs disease
-
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol
-
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
-
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture
-
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
-
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimerâs Disease
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation
-
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection
-
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimerâs Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline
-
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling
-
The role of cannabinoids and leptin in neurological diseases
-
Advancements in the treatment of agitation in Alzheimerâs disease
-
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol
-
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimerâs Disease
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
-
Endocannabinoid regulation of amyloid-induced neuroinflammation
-
Endocannabinoids and Neurodegenerative Disorders: Parkinsonâs Disease, Huntingtonâs Chorea, Alzheimerâs Disease, and Others
-
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimerâs disease
-
The basolateral amygdala γ-aminobutyric acidergic system in health and disease
-
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities
-
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimerâs disease mouse model
-
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
-
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C
-
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta
-
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
-
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions
-
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimerâs disease
-
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimerâs Disease and Mild Cognitive Impairment
-
Endocannabinoids in Cerebrovascular Regulation
-
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimerâs Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine
-
Pharmacological management of agitation and aggression in Alzheimerâs Disease: a review of current and novel treatments
-
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimerâs disease
-
Investigational drugs for treating agitation in persons with dementia
-
Fatty acid amide hydrolase (FAAH), acethylcholinesterase (AChE) and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti Alzheimerâs Disease agents
-
Endocannabionoid System in Neurological Disorders
-
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States
-
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimerâs disease
-
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice
-
Type-2 cannabinoid receptors in neurodegeneration
-
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
-
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia
-
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia
-
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis
-
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
-
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
AMOTIVATIONAL SYNDROME (5)
-
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats
-
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses
-
So called âsoftâ drugs: cannabis and the amotivational syndrome
-
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions
-
Î9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats.
ANGELMANâS SYNDROME (1)
ANGIOGENESIS (36)
-
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
-
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator
-
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?
-
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis
-
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis
-
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
-
Cannabidiol inhibits angiogenesis by multiple mechanisms
-
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats
-
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Non small Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation
-
Autophagy triggered by magnolol derivative negatively regulates angiogenesis
-
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K / AKT / mTOR signaling pathway in mES / EB-derived endothelial-like cells
-
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line
-
Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/akt signaling pathways
-
A new strategy to block tumor angiogenesis by inhibiting endocannabinoid inactivation
-
Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis
-
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
-
Anandamide inhibits breast tumor-induced angiogenesis
-
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases
-
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation
-
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
-
The use of cannabinoids as anticancer agents
-
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis
-
New insights into antimetastatic and antiangiogenic effects of cannabinoids
-
Differential role of cannabinoids in the pathogenesis of skin cancer
-
Endocannabinoids and Cancer
-
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
-
Endocannabinoids as Guardians of Metastasis
-
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
-
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
-
Integrating cannabis into clinical cancer care
-
Antitumorigenic targets of cannabinoids â current status and implications
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
-
Anticancer mechanisms of cannabinoids
-
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation
ANOREXIA/ANOREXIA NERVOSA (29)
-
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2
-
Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake
-
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands
-
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals
-
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
-
The genetics of eating disorders
-
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
-
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa
-
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
-
The role of the endocannabinoid system in eating disorders: pharmacological implications
-
Do deficits in brain cannabinoids contribute to eating disorders?
-
Brain Molecules and Appetite: The Case of Oleoylethanolamide
-
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence
-
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa
-
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders
-
Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population
-
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial
-
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial
-
The endocannabinoid system and appetite: relevance for food reward
-
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa
-
ENP11, a potential CB1R antagonist, induces anorexia in rats
-
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial
-
Endocannabinoids and Metabolic Disorders
-
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study
-
Cannabinoid hyperemesis syndrome masquerading as an eating disorder
-
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study
-
Role of cannabis in digestive disorders
ANTI-BACTERIAL PROPERTIES (13)
-
Antibacterial analysis of crude extracts from the leaves of Tagetes erecta and Cannabis sativa
-
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa
-
Screening for Antiviral Activities of Isolated Compounds from Essential Oils
-
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
-
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV
-
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections
-
Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi
-
Î9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
-
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA)
-
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model
-
Screening of cannabinoids in industrial-grade hemp using two-dimensional liquid chromatography coupled with acidic potassium permanganate chemiluminescence detection
-
Reducing exposure to pathogens in the horse. A preliminary study into the survival of bacteria on a range of equine bedding types
-
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis
ANTI-FUNGAL PROPERTIES (5)
-
Antimicrobial Activity of Cannabis sativa L.
-
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa
-
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans
-
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa
-
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis
ANTI-PARASITIC PROPERTIES (1)
ANTI-PROTOZOAL PROPERTIES (4)
ANTIOXIDANT PROPERTIES (42)
-
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice
-
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
-
Effect of cannabidiol treatment in alimentary induced fatty liver
-
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds
-
Review article: The endocannabinoid system in normal and pathological brain ageing
-
Î(8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors
-
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
-
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats
-
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L.)
-
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats
-
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
-
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase
-
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
-
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans
-
Neuroprotective Properties of Cannabigerol in Huntingtonâs Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
-
Increased oxidative stress enhances endocannabinoid tone
-
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury
-
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Î9 -THC
-
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice
-
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities
-
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells
-
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats
-
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
-
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids
-
CB2 Cannabinoid Receptor As Potential Target against Alzheimerâs Disease
-
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats
-
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
-
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinsonâs Disease
-
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
-
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
-
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats
-
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
-
The role of perivascular adipose tissue in obesity-induced vascular dysfunction
-
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase
-
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis
-
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors
-
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice
ANXIETY/ANXIOLYTIC EFFECTS (247)
-
Cannabis Overdose
-
Mixed mood disorder
-
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy
-
Anxiety Associated with Dying
-
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Anti-anxiety Effects of Fatty Acid Amide Hydrolase Inhibition
-
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?
-
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
-
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
-
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
-
Cannabinoids and anxiety
-
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety
-
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
-
Panic Attack after Spice Abuse in a Patient with ADHD
-
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress
-
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
-
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
-
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
-
Cannabinoids and emotionality: a neuroanatomical perspective
-
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
-
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
-
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy
-
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats
-
Personalized medicine can pave the way for the safe use of CBâ receptor antagonists
-
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotionalâmotivational reactivity
-
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission
-
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
-
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone
-
Interleukin-1β causes anxiety by interacting with the endocannabinoid system
-
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
-
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice
-
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
-
Cannabidiol in humans-the quest for therapeutic targets
-
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats
-
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats
-
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
-
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251
-
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors
-
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
-
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
-
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
-
Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response
-
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview
-
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
-
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it
-
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
-
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
-
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
-
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour
-
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009
-
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
-
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations
-
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists
-
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
-
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction
-
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning
-
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress
-
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test
-
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional, Features, and Emerging Specificities of the Two Major Endocannabinoids
-
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test
-
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?
-
Effect of dietary fat type on anxiety-like and depression-like behavior in mice
-
Endocannabinoid system and mood disorders: Priming a target for new therapies
-
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses
-
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
-
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors
-
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex
-
Cannabinoid facilitation of fear extinction memory recall in humans
-
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade
-
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?
-
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
-
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
-
Dissociation of the Pharmacological Effects of THC by mTOR Blockade
-
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
-
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)
-
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor
-
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats
-
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale
-
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments
-
CB1 receptor signaling regulates social anxiety and memory
-
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms
-
Cannabidiol enhances consolidation of explicit fear extinction in humans
-
Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice
-
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat
-
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats
-
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behaviorand saccharin palatability
-
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral peri-aqueductal gray in rats
-
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats
-
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat
-
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria
-
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activity in the elevated T-maze
-
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
-
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression
-
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats
-
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males
-
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)
-
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
-
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders
-
Cannabis use motives and personality risk factors
-
The endocannabinoid system: An emotional buffer in the modulation of memory function
-
Cannabis use in a Swiss male prison: Qualitative study exploring detaineesâ and staffsâ perspectives
-
Therapeutic benefits of cannabis: a patient survey
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
-
How Cannabis Causes Paranoia: Using the Intravenous Administration of â9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia
-
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
-
Cannabis use and anxiety: is stress the missing piece of the puzzle?
-
Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray
-
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity
-
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors
-
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
-
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
-
Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
-
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder
-
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat
-
Stress regulates endocannabinoid-CB1 receptor signaling
-
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
-
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
-
Inhibition of FAAH enzyme by pterostilbene: potential mechanism of anxiolytic action
-
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs
-
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats
-
Anxiogenic-like effects induced by hemopressin in rats
-
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases
-
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
-
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS
-
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity
-
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system
-
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
-
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs Through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
-
FAAH genetic variation enhances fronto-amygdala function in mouse and human
-
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety like behavior and unaltered seizure susceptibility
-
Cannabis and Cannabinoidsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
Targeting the endocannabinoid system to treat anxiety-related disorders
-
The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA
-
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Neural correlates of cannabidiol and Î9-tetrahydrocannabinol interactions in mice: implications for medical cannabis
-
Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
-
Fluoxetine Facilitates Fear Extinction through Amygdala Endocannabinoids
-
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder
-
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
-
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxietylike behavior and sociability
-
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
-
Cannabis use, depression and anxiety: A 3-year prospective population-based study
-
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence
-
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses
-
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression
-
Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats
-
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling
-
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice
-
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and anti-depressive drugs-A practical view
-
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
-
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
-
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon
-
CB1 receptors modulate affective behaviour induced by neuropathic pain
-
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels
-
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
-
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake
-
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors
-
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
-
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
-
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence from Two Recent Genetic Endocannabinoid Deficiency Models
-
Genetic deletion of monoacylglycerol lipase (MAGL) leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior
-
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimerâs Disease
-
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats
-
Endocannabinoid regulation of amyloid-induced neuroinflammation
-
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats
-
Endocannabinoids and Mental Disorders
-
A runnerâs high depends on cannabinoid receptors in mice
-
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea
-
Mechanisms of stress in the brain
-
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats
-
The basolateral amygdala γ-aminobutyric acidergic system in health and disease
-
The endocannabinoid system in guarding against fear, anxiety and stress
-
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
-
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies
-
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
-
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning
-
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development
-
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala
-
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance
-
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus
-
The association between cannabis use and anxiety disorders: Results from a population based representative sample
-
The association between cannabis use and anxiety disorders: Results from a population based representative sample
-
Cannabidiol as a Potential Treatment for Anxiety Disorders
-
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students
-
Mediating processes between stress and problematic marijuana use
-
Runnerâs high linked to cannabinoid receptors in mice
-
Cannabinoid Receptors May Control Aversive Memories
-
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety -Like Behaviors in Male Rat Offspring
-
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
-
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala
-
Facilitatory effect of AM281 on recognition memory in rats
-
Interactions between anandamide & corticotropin-releasing hormone signaling modulate human amygdala function & risk for anxiety disorders: An imaging genetics strategy for modeling molecular interactions
-
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea
-
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
-
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
-
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats
-
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning
-
A systematic review of plant-derived natural compounds for anxiety disorders
-
Concentration, population, and context-dependent effects of AM251 in zebrafish
-
Involvement of M1 and CB1 receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
-
Cannabidiol, neuroprotection and neuropsychiatric disorders
-
Placebo effect: clinical, biological and therapeutical involvements in depression
-
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal
-
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene
-
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
-
Interactions Between Anandamide and Corticotropin-Releasing Hormone Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions
-
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
-
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus
-
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
-
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological â cardiac comorbidity?
-
Evidences for the anti-panic actions of Cannabidiol
-
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions
-
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependentI nteraction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus.
-
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor
-
The association between cannabis use and anxiety disorders: Results from a populationbased representative sample
-
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users
-
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
-
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings.
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents
-
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder
-
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice
-
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala
-
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
-
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
-
Contribution of health motive to cannabis use among high-school students
-
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
-
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat
-
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
-
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex
-
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
-
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus
-
Targeting the Endocannabinoid System in Psychiatric Illness
-
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives.
-
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
-
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
-
Chapter Eight â The Endocannabinoid System and Anxiety
-
Treating Depression in Alcoholics
-
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA
-
Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis
-
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit
APPETITE (211)
-
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin
-
The multiple functions of the endocannabinoid system: a focus on the regulation of food intake
-
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype
-
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice
-
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice
-
Endocannabinoid control of gastric sensorimotor function in man
-
Cannabidiol Attenuates the Appetitive Effects of Î9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
-
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
-
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food reinforced behavior
-
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
-
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors
-
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
-
Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors
-
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
-
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats
-
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands
-
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation
-
PP-014 Control of receptor expression in vagal afferent neurons by activation of cannabinoid 1 receptors
-
Bimodal control of stimulated food intake by the endocannabinoid system
-
Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish
-
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanol-amide in reducing body fat gain in C3H mice
-
AM 251 differentially effects food-maintained responding depending on food palatability
-
A low-Î9tetrahydrocannabinol cannabis extract induces hyperphagia in rats
-
The endocannabinoid system modulates the valence of the emotion associated to food ingestion
-
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
-
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity
-
The neutral cannabinoid CBâ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
-
Effect of rimonabant on oesophageal motor function in man
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
-
Fish oil promotes survival and protects against cognitive decline in severely under-nourished mice by normalizing satiety signals
-
Gut fat sensing in the negative feedback control of energy balance â recent advances
-
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
-
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
-
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation
-
Cannabidiol potentiates Î(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
-
Non-Î9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats
-
Medical cannabis: the opportunity versus the temptation
-
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors
-
Cannabinoids in children
-
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance
-
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks
-
Ghrelin-mediated appetite regulation in the central nervous system
-
Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity
-
Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats
-
Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences
-
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses
-
Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats
-
Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice
-
G-Protein-Coupled Receptors in Intestinal Chemosensation
-
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats
-
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats
-
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake
-
The thrifty lipids: endocannabinoids and the neural control of energy conservation
-
Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice
-
GPR119 as a fat sensor
-
Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behavior
-
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration
-
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
-
The potential use of cannabidiol in the therapy of metabolic syndrome
-
Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats
-
Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered Signalling at CB1 Receptors in Siberian Hamsters
-
The role of the endocannabinoid system in eating disorders: pharmacological implications
-
Modulation of sweet responses of taste receptor cells
-
Non-Îâ¹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats
-
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
-
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism
-
Food for thought: hormonal, experiential, and neural influences on feeding and obesity
-
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking
-
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats
-
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons
-
Cannabinoids, eating behaviour, and energy homeostasis
-
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism
-
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes
-
The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake
-
Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner
-
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade
-
Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids
-
Therapeutic potential of cannabinoid medicines
-
Orexin neurons use endocannabinoids to break obesity-induced inhibition
-
Developmental Role for Endocannabinoid Signaling in Regulating Glucose Metabolism and Growth
-
Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2
-
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids
-
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale
-
Brain Molecules and Appetite: The Case of Oleoylethanolamide
-
Effect of Diet on Tissue Levels of Palmitoylethanolamide
-
Cannabis and Î(9)-tetrahydrocannabinol (THC) for weight loss?
-
Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals
-
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
-
Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity
-
Central functional response to the novel peptide cannabinoid, hemopressin
-
The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food
-
Cannabinoid receptors and cholecystokinin in feeding inhibition
-
The endocannabinoid system in obesity
-
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence
-
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons
-
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating
-
The regulation of food intake by the gut-brain axis: implications for obesity
-
Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high carbohydrate diet
-
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite
-
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice
-
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic NAcylethanolamines
-
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial
-
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats
-
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
-
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet
-
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet]
-
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats
-
Marijuana and Body Weight
-
Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats
-
Rimonabantâs reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats
-
Î9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/âSpiceâ constituent JWH-018 in mice
-
Is fat taste ready for primetime?
-
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
-
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
-
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats
-
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers
-
Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans
-
Oleoylethanolamide and Human Neural Responses to Food Stimuli in Obesity
-
Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide
-
Baseline Anandamide Levels and Body Weight Impact the Weight Loss Effect of CB1 Receptor Antagonism in Male Rats
-
Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus Inhibit Stimulated Food Intake
-
The endocannabinoid system controls food intake via olfactory processes
-
Food intake regulation â 2nd part
-
Classical endocannabinoid-like compounds and their regulation by nutrients
-
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat
-
Endocannabinoids and energy homeostasis: An update
-
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
-
The endocannabinoid system and appetite: relevance for food reward
-
A Vapourized Î9-Tetrahydrocannabinol (Î9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents
-
GPR55: From orphan to metabolic regulator?
-
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation
-
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets
-
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders
-
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system
-
Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans
-
Truffles contain endocannabinoid metabolic enzymes and anandamide
-
The role of gut hormones in appetite regulation (review)
-
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice
-
Role of oleoylethanolamide as a feeding regulator in goldfish
-
The endocannabinoid system: directing eating behavior and macronutrient metabolism
-
Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Î9-tetrahydrocannabinol (THC)
-
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression
-
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons
-
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
-
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
-
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa
-
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebrospinal Fluid of Patients with Osteoarthritis
-
Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein
-
Effects of high-fructose diets on central appetite signaling and cognitive function
-
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice
-
Hypothalamic POMC neurons promote cannabinoid-induced feeding
-
Cannabis and Cannabinoidsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults
-
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Î9-Tetrahydrocannabinol
-
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
-
Intestinal lipid-derived signals that sense dietary fat
-
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study
-
The role of AMP-activated protein kinase (AMPK) in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis
-
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macro-nutrient intakes in obese females
-
Role of cannabinoidergic system on food intake in neonatal layer-type chicken
-
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
-
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior
-
Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken
-
ENP11, a potential CB1R antagonist, induces anorexia in rats
-
A pivotal role for enhanced brainstem orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats
-
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat
-
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans
-
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial
-
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways
-
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors
-
New insights on the role of the endocannabinoid system in the regulation of energy balance
-
Endocannabinoids and Metabolic Disorders
-
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metaboliic Disease
-
Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies
-
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol
-
Endocannabinoid Regulation of Neuroendocrine Systems
-
CB1 receptors into the Prelimbic Cortex modulate food intake in rats
-
Interaction Between Endocannabinoid and Opioidergic Systems Regulates Food Intake in Neonatal Chicken
-
Cannabis: a self-medication drug for weight management? The never ending story
-
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction
-
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring
-
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity
-
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes
-
Opioid and Cannabinoid System in Food Intake
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review
-
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.
-
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
-
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice.
-
Regulation of Growth Hormone by the Splanchnic Area.
-
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
-
Identification of the oleic acid ethanolamide (OEA) isomer cis-vaccenic acid ethanolamide (VEA) as a highly abundant 18:1 fatty acid ethanolamide in blood plasma from rats and humans
-
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
-
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
-
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system
-
Disturbances of sleep and circadian rhythms: novel risk factors for obesity
-
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation
-
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index
-
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors
-
Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding
-
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity
-
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis
-
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R
-
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9- tetrahydrocannabinol, elicits hyperphagia in rats
ARTHRITIS (71)
-
Tissue Engineering of Cartilage . Can Cannabinoids Help?
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression
-
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteo-arthritic knee joint pain
-
Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain
-
Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of proinflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage
-
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
Cannabinoids for Treatment of Chronic Non-Cancer Pain a Systematic Review of Randomized Trials
-
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice
-
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
-
Medical cannabis: the opportunity versus the temptation
-
Expression of cannabinoid receptors by human articular chondrocytes
-
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level
-
Dynamic changes to the endocannabinoid system in models of chronic pain
-
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?
-
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system
-
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system
-
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
-
Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2
-
Cannabinoids: novel therapies for arthritis?
-
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate
-
Neuromodulators for pain management in rheumatoid arthritis
-
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain
-
Role of type 2 cannabinoid receptors in osteoarthritis
-
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum
-
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint
-
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
-
Osteoarthritis pain mechanisms: basic studies in animal models
-
Cannabinoid WIN-55,212-2 Mesylate Inhibits Interleukin-1β Induced Matrix Metalloproteinase and Tissue Inhibitor of Matrix Metalloproteinase Expression in Human Chondrocytes
-
Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes
-
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint
-
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
-
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
-
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
-
High hopes for cannabinoid agonists in the treatment of rheumatic diseases
-
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis
-
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints
-
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model
-
Medical Cannabis Research, What the Science Says
-
Involvement of the endocannabinoid system in osteoarthritis pain
-
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells
-
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells
-
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebro-spinal Fluid of Patients with Osteoarthritis
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.
-
Cannabis â the Israeli perspective
-
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Endocannabinoids and acute pain after total knee arthroplasty
-
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis
-
Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis
-
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
-
A multi-target approach for pain treatment â dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis
-
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice
-
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis
-
Role of the endocannabinoid system in the emotional manifestations of osteo-arthritis pain
-
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review
-
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials
-
INF/IR-15: ADELMIDROL, A PALMITOYLETHANOLAMIDE ANALOGUE, AS A NEW PHARMACOLOGICAL TREATMENT FOR THE MANAGEMENT OF INFLAMMATORY PAIN
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats
-
Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1.
-
Cannabinoids and autoimmune diseases: A systematic review
-
MEDICAL CANNABIS
-
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain
-
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism
-
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
-
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
ASTHMA (23)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors
-
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
The role of CB2 receptor ligands in human eosinophil function
-
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
-
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
-
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation
-
The expression of cannabinoid receptor 1 is significantly increased in atopic patients
-
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors
-
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
-
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice
-
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways.
-
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice
-
Î9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors
-
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
ATAXIA (6)
-
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling
-
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
-
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?
-
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
-
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias
-
Buzz Juice: Neurological sequelae of synthetic cannabinoids
ATHEROSCLEROSIS (44)
-
US Patent Application 20100158973 â THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS
-
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice
-
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
-
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
-
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo
-
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits
-
Cannabinoids and atherosclerotic coronary heart disease
-
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice
-
Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies
-
The potential use of cannabidiol in the therapy of metabolic syndrome
-
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology
-
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation
-
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice
-
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport
-
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection
-
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
-
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system
-
Anti-atherosclerosis role of N-oleoylethanolamine in CB2
-
Increased oxidative stress enhances endocannabinoid tone
-
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
-
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
-
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque and improves plaque stability in ApoE-knockout mice
-
Oxyradical Stress, Endocannabinoids, and Atherosclerosis
-
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimerâs Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
Endocannabinoids and the Cardiovascular System in Health and Disease
-
Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice
-
Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque
-
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
The CB2 receptor and its role as a regulator of inflammation
-
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α
-
Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS
-
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages
-
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis
-
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
-
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase
-
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalulation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis
AUTISM (27)
-
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child
-
Can autism be triggered by acetaminophen activation of the endocannabinoid system?
-
Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for happy faces
-
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders
-
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
-
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
-
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders (link to
-
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders
-
Alterations in the endocannabinoid system in the rat valproic acid model of autism
-
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
-
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
-
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling
-
Endocannabinoid signaling mediates oxytocin-driven social reward
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Endocannabinoid Signaling in Autism
-
Endocannabinoids and Mental Disorders
-
The basolateral amygdala γ-aminobutyric acidergic system in health and disease
-
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling
-
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of âBliss Moleculeâ
-
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
-
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
-
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (click âFull Text Linksâ for
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid
-
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders